Heard from some on the other board who think of Prurisol as a nice throw in to the mix, nothing more and yet on most every other board a product that could bring the SP from $1.57 or so to $15 with an upside to $25-30 it would be viewed as a phenom!  Guess we are pretty spoiled to have such a great product, with such strong support for a successful trial, viewed as just a throw in product.

IMO, those with psoriasis view Prurisol as the star just as cancer patients view Kevetrin as the star.

Kevetrin may be the knockout punch, but Prurisol is certainly the stinging jab (ala Ali) that keeps CTIX in the game waiting for the big punch.

Very happy to hear LE has approved of the idea of interviews to bring stockholders up to date as much as possible with confidentiality requirements.  He always has been able to throw in a few bones to sweeten the pot regarding info we hadn't previously heard.